Zinbryta®
Company
Biogen
Use
Treatment of HIV-1 infection.
Features
An injectable antibody targeting interleukin-2 receptors, FDA approved in 2016.
NIH Contribution
NIH research in multiple sclerosis contributed to the development of biologics.
HHS Institute/Agency
NINDS
Inventor(s)
Bielekova, B. et al.
Year
2016
